Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Harm Reduct J ; 20(1): 37, 2023 03 24.
Article in English | MEDLINE | ID: mdl-36964600

ABSTRACT

BACKGROUND: Distribution of naloxone and training on its proper use are evidence-based strategies for preventing opioid overdose deaths. In-person naloxone training was conducted in major metropolitan areas and urban centers across Texas as part of a state-wide targeted opioid response program. The training program transitioned to a live, virtual format during the COVID-19 public health emergency declaration. This manuscript describes the impact of this transition through analyses of the characteristics of communities reached using the new virtual training format. CASE PRESENTATION: Training participant addresses were compared to county rates of opioid overdose deaths and broadband internet access, and census block comparison to health services shortages, rural designation, and race/ethnicity community characteristics. CONCLUSIONS: The virtual training format reached more learners than the in-person events. Training reached nearly half of the counties in Texas, including all with recent opioid overdose deaths. Most participants lived in communities with a shortage of health service providers, and training reached rural areas, those with limited broadband internet availability, and majority Hispanic communities. In the context of restrictions on in-person gathering, the training program successfully shifted to a live, online format. This transition increased participation above rates observed pre-pandemic and reached communities with the need for equipping those most likely to witness an opioid overdose with the proper use of naloxone.


Subject(s)
COVID-19 , Drug Overdose , Opiate Overdose , Humans , Narcotic Antagonists/therapeutic use , Pandemics/prevention & control , Drug Overdose/prevention & control , Drug Overdose/drug therapy , Opiate Overdose/prevention & control , Opiate Overdose/drug therapy , Texas/epidemiology , COVID-19/prevention & control , Naloxone/therapeutic use , Analgesics, Opioid/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL